Clinical-Nutritionist Wellness Guides for Indian Adults
Five long-form, evidence-led wellness guides — each reviewed by Ms. Kalpana Gupta, Senior Clinical Nutritionist. Each guide walks through ingredient evidence, dose ranges from published trials, drug interactions with common Indian prescription brands, religious-fasting considerations, and the foundational interventions that out-perform any supplement.
Joint & Bone Health
Decision-tree from a hospital nutritionist: match your symptom pattern (mechanical pain, stiffness, post-menopausal, NSAID-intolerant) to glucosamine, UC-II, K2, boswellia or magnesium. Drug-interaction matrix with Indian generics.
Read the guide →Metabolic & Diabetes Support
Built around the thin-fat Indian phenotype: ICMR-INDIAB Phase 5 data, Asian-Indian BMI cut-offs, religious-fasting protocols (Karwa Chauth, Ramadan, Navratri, Ekadashi), and full drug-interaction matrix with Glycomet/Glynase/Galvus.
Read the guide →Weight Management
Three real clinical case studies — Bengaluru IT professional (prediabetic), Mumbai mother (hypothyroid), Punjabi retired Army officer (polypharmacy). What worked, what was rejected, and why.
Read the guide →Heart & Circulation
The South Asian cardiovascular paradox: 10-year-earlier onset, elevated Lp(a) prevalence, INTERHEART and MASALA findings. Omega-3, CoQ10, K2, aged garlic with interaction warnings for Indian brands.
Read the guide →Hair, Skin & Beauty
Diagnostic flowchart approach — classify the pattern first (shedding vs thinning vs patchy), test before supplementing (ferritin, vitamin D, thyroid, B12, zinc), then choose. Post-COVID telogen effluvium data and Indian hard-water context.
Read the guide →How these guides are built
Every guide combines three layers: ingredient evidence with published PubMed references, India-specific clinical context (ICMR data, FSSAI nutraceutical framework, Indian generic drug interactions), and realistic effect-size framing (what to expect, what not to expect). None of these guides will tell you a supplement "treats" or "cures" a disease — under Indian regulation, nutraceuticals cannot make therapeutic claims, and our editorial review enforces that line.